首页> 外文期刊>Indian journal of surgical oncology >Estimation of Serum MicroRNA 21 as a Tumour Marker in Carcinoma Oesophagus
【24h】

Estimation of Serum MicroRNA 21 as a Tumour Marker in Carcinoma Oesophagus

机译:血清MicroRNA 21作为癌食管中肿瘤标志物的估计

获取原文
       

摘要

Worldwide, carcinoma of the oesophagus is the sixth leading reason for deaths due to malignancy. MicroRNAs (MiRs) are a cluster of small non-coding RNAs that have potent stability in stored RNA samples. This strengthens their potential as biomarkers. This study aimed to isolate MiR 21 from serum samples of carcinoma oesophagus patients and healthy subjects for determining its strength of association in various stages of the carcinoma oesophagus. This is a case–control study with 1:1 matched cases and controls. We included 40 patients of carcinoma oesophagus and 40 healthy individuals. Serum separated from venous blood samples of cases and controls was stored at???80?°C. Total RNA was extracted, and the real-time polymerase chain reaction was used to measure the serum MiR 21. On statistical comparison, we found a marked increase in MiR 21 in cases of carcinoma oesophagus when compared with the controls (p?
机译:在全球范围内,食道癌是由于恶性肿瘤导致死亡的第六个主要原因。 MicroRNA(MIRS)是一组小的非编码RNA,其在储存的RNA样品中具有有效的稳定性。这加强了它们作为生物标志物的潜力。本研究旨在将MIR 21分离出MiR 21来自癌食管患者的血清样本和健康受试者,以确定其在癌食管的各个阶段中的关联强度。这是一个案例对照研究,具有1:1匹配的病例和控制。我们包括40名癌食管和40名健康个体患者。将血清与静脉血液样品分离,并将对照储存在β0.℃。提取总RNA,使用实时聚合酶链式反应测量血清miR 21.关于统计比较,我们发现与对照组的癌食管癌食管的情况下MiR 21的显着增加(P?<?0.0001 )。本研究还表明miR 21水平稳步上升,疾病严重程度(p?<β0101)。基于本研究的结果,我们得出结论,MIR 21水平可用作用于评估癌食管中疾病严重程度的新型标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号